首页 | 本学科首页   官方微博 | 高级检索  
     


Tumor Targeting: Dual Targeted Immunotherapy via In Vivo Delivery of Biohybrid RNAi‐Peptide Nanoparticles to Tumor‐Associated Macrophages and Cancer Cells (Adv. Funct. Mater. 27/2015)
Authors:João Conde  Chenchen Bao  Yeqi Tan  Daxiang Cui  Elazer R. Edelman  Helena S. Azevedo  Hugh J. Byrne  Natalie Artzi  Furong Tian
Affiliation:1. Massachusetts Institute of Technology, Institute for Medical Engineering and Science, Harvard‐MIT Division for Health Sciences and Technology, Cambridge, MA, USA;2. School of Engineering and Materials Science, Queen Mary University of London, London, UK;3. Institute of Nano Biomedicine and Engineering, Key Laboratory of Thin Film and Micro/Nano Fabrication Technology of Ministry of Education, School of Electronic Information and Electronical Engineering, National Center for Translational Medicine, Shanghai Jiao Tong University, Shanghai, P. R. China;4. Focas Research Institute, Dublin Institute of Technology, Camden Row, Dublin 8, Ireland;5. Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA;6. Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
Abstract:
Keywords:lung cancer  nanoparticles  RNAi  tumor‐associated macrophages  tumor targeting
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号